Tag: cell in a box technology

April 3, 2017

PharmaCyte Appoints Director Of Cannabis Program

PharmaCyte Biotech clinical stage biotechnology company announced a new side of the company by naming Dr. Mark L. Rabe as...
February 21, 2017

PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its...
February 13, 2017

PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its...
January 30, 2017

PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its...
January 4, 2017

PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its...
December 27, 2016

PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its...
December 15, 2016

PharmaCyte Biotech Submits Pre-IND Meeting Package to FDA

PharmaCyte Biotech announced today that it has submitted its pre-Investigational New Drug (pre-IND) meeting package to the U.S. Food and...